Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies

Journal of Allergy and Clinical Immunology(2025)10.1016/j.jaci.2025.10.031Source: DataRank Database

Exploratory analyses of predictors and correlates of response to omalizumab therapy in patients with multiple food allergies is a research paper published in Journal of Allergy and Clinical Immunology (2025). On theSindex it has a DataRank of 0. It has been cited 7 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access7 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (20 grants)Impact (FWCI 5.25)OA: greenTopics (45)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (34)

Michael D. Kulis ORCID,Stacie M. Jones ORCID,Scott H. Sicherer ORCID,Julie Wang ORCID,Wayne G. Shreffler ORCID

Live enrichment

PubMed:41238005 PMC:PMC12867313 OpenAlex:https://openalex.org/W4416197680

NIAID NIH HHS

Grant: U01 AI181962

NCATS NIH HHS

Grant: UL1 TR003107

NIAID NIH HHS

Grant: U01 AI181883

NIAID NIH HHS

Grant: UM1 AI130781

NCATS NIH HHS

Grant: UL1 TR002378

NCATS NIH HHS

Grant: UL1 TR003098

NCATS NIH HHS

Grant: UM1 TR004406

NCATS NIH HHS

Grant: UM1 TR004399

NCATS NIH HHS

Grant: UM1 TR004408

NCATS NIH HHS

Grant: UL1 TR002535

NIAID NIH HHS

Grant: UM1 AI130936

NIAID NIH HHS

Grant: UM1 AI130570

NIAID NIH HHS

Grant: UM2 AI130836

NCATS NIH HHS

Grant: UL1 TR001878

NIAID NIH HHS

Grant: UM1 AI130838

NIAID NIH HHS

Grant: U01 AI178772

NIAID NIH HHS

Grant: UM1 AI130839

Genentech Inc

National Institutes of Health

Novartis Pharmaceuticals Corporation

FWCI

5.25

Citation Percentile

1.0%

Citation Trend

2026

greenLicense: cc-by-nc-nd

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/12867313

publisherhttps://api.elsevier.com/content/article/PII:S0091674925011248?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0091674925011248?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jaci.2025.10.031

Fields of Study

Food Allergy and Anaphylaxis ResearchCeliac Disease Research and ManagementEosinophilic EsophagitisHumansOmalizumabFood HypersensitivityFemaleMaleAnti-Allergic AgentsImmunoglobulin EAdultChildAdolescentAllergensTreatment OutcomeYoung AdultMiddle AgedChild, Preschool

MeSH Terms

OmalizumabAdolescentAdultAllergensChildChild, PreschoolFemaleFood HypersensitivityHumansImmunoglobulin EMaleMiddle AgedTreatment OutcomeAnti-Allergic AgentsYoung Adult

Keywords

OmalizumabAllergyFood allergyDosingPeanut allergyImmunoglobulin EIgEAnti-IgEPredictorsCorrelatesBasophil ActivationFood Challenges